Longevity PapersAbout
← All papers
RESEARCH PAPER / 2025-10-01

In vitro and in vivo investigation of the capacity of mulberroside A to inhibit senescence.

Yang Liu, Mingfei Chen, Cong Chen, Gao Huang

College of Traditional Chinese Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China. [email protected]. · pubmed

Abstract

Mulberroside A, naturally existent from the mulberry plant, is known for its diverse biological activities. Our research indicates that mulberroside A may possess significant anti-aging effects. We assessed its anti-aging properties using naturally aging animal models and by inducing senescence in human-derived endothelial cells and mouse-derived endothelial cells through treatment with angiotensin II. We found that mulberroside A promotes the proliferation of HMEC-1 and bEnd.3 endothelial cells, while significantly reducing the levels of senescence biomarkers p16, p21, and Rb in both these endothelial cell types and in the hippocampus, kidney, spleen and liver of naturally aging animals. Additionally, mulberroside A was found to mitigate telomerase depletion in the blood of naturally aging animals, enhance the body's resistance ability to oxidative stress, and inhibit the overexpression of inflammatory factors in vivo.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

Mulberroside A has the capacity to inhibit cellular senescence and promote proliferation in endothelial cells. The study addresses mechanisms related to aging and senescence, which are central to longevity research.

Author of this paper? Send a correction.